GENEWIZ

GENEWIZ is a genomics services company and providing Sanger sequencing, next-generation sequencing, gene synthesis, oligo synthesis and bioinformatics services to pharmaceutical, biotechnology and academic customers worldwide.

Its services span whole genome sequencing, RNA-seq, single-cell sequencing, metagenomics and spatial transcriptomics, with GLP-compliant and clinical-grade options available.

GENEWIZ is a certified Oxford Nanopore Technologies sequencing service provider and in 2025 partnered with Form Bio to deliver integrated long-read sequencing and AI analysis for AAV gene therapy development.